User:Mr. Ibrahem/Cabazitaxel

Cabazitaxel, sold under the brand name Jevtana, is a medication used to treat prostate cancer. Specifically it is used for metastatic castration-resistant prostate cancer who have failed other treatment. It is given by injection into a vein.

Common side effects include low red blood cells, low white blood cells, low platelets, and diarrhea. Other side effects may include allergic reactions and kidney problems. It is a taxane which interferes with microtubules.

Cabazitaxel was approved for medical use in the United States in 2010 and Europe in 2011. In the United Kingdom 60 mg costs the NHS about £3,700 as of 2021. This amount in the United States costs about 12,700 USD.